Genotoxic sensitivity of the developing hematopoietic system

Mutation Research - Reviews in Mutation Research

Volumn 767, Issue , 2016, Pages 1-7

  Udroiu, Ion ^a   Sgura, Antonella ^a  

^a ROMA TRE UNIVERSITY   (Italy)

Author keywords

Fetal; Genotoxicity; Hemopoietic; Human; Infant; Murine

Indexed keywords

DNA DAMAGE; GENOTOXICITY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC SYSTEM; HUMAN; INFANCY; MICRONUCLEUS; MICRONUCLEUS TEST; NONHUMAN; ONTOGENY; PRIORITY JOURNAL; REVIEW; ANIMAL; DNA REPAIR; EMBRYOLOGY; FEMALE; GENETICS; METABOLISM; MOUSE; PREGNANCY;

MUTAGENIC AGENT;

ANIMALS; DNA DAMAGE; DNA REPAIR; FEMALE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HEMATOPOIETIC SYSTEM; HUMANS; MICE; MICRONUCLEUS TESTS; MUTAGENS; PREGNANCY;

EID: 84961121718     PISSN: 13835742     EISSN: 13882139     Source Type: Journal    
DOI: 10.1016/j.mrrev.2015.12.001     Document Type: Review

References (66)

1. Eaves C.J. Hematopoietic stem cells: concepts, definitions, and the new reality. Blood 2015, 125:2605-2613.
2. Palis J. Primitive and definitive erythropoiesis in mammals. Front. Physiol. 2014, 28(January (5)):3.
3. Ciau-Uitz A., Monteiro R., Kirmizitas A., Patient R. Developmental hematopoiesis: ontogeny, genetic programming and conservation. Exp. Hematol. 2014, 42(August (8)):669-683.
4. Babovic S S., Eaves C.J. Hierarchical organization of fetal and adult hematopoietic stem cells. Exp. Cell Res. 2014, 329:185-191.
5. Tober J., Koniski A., McGrath K.E., Vemishetti R., Emerson R., de Mesy-Bentley K.K., Waugh R., Palis J. The megakaryocyte lineage originates from hemangioblast precursors and is an integral component both of primitive and of definitive hematopoiesis. Blood 2007, 109:1433-1441.
6. Palis J., Robertson S., Kennedy M., Wall C., Keller G. Development of erythroid and myeloid progenitors in the yolk sac and embryo proper of the mouse. Development 1999, 126:5073-5084.
7. Palis J., Chan R.J., Koniski A., Patel R., Starr M., Yoder M.C. Spatial and temporal emergence of high proliferative potential hematopoietic precursors during murine embryogenesis. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:4528-4533.
8. Godin I., Dierterlen-Lievre F., Cumano A. Emergence of multipotent hematopoietic cells in the yolk sac and paraaortic splanchnopleura in mouse embryos, beginning at 8.5 days postcoitus. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:773-777.
9. Ottersbach K., Dzierzak E. The placenta as a haematopoietic organ. Int. J. Dev. Biol. 2010, 54:1099-1106.
10. Rebel V.I., Miller C.L., Eaves C.J., Lansdorp P.M. The repopulation potential of fetal liver hematopoietic stem cells in mice exceeds that of their liver adult bone marrow counterparts. Blood 1996, 87:3500-3507.
11. Ema H., Nakauchi H. Expansion of hematopoietic stem cells in the developing liver of a mouse embryo. Blood 2000, 95:2284-2288.
12. Christensen J.L., Wright D.E., Wagers A.J., Weissman I.L. Circulation and chemotaxis of fetal hematopoietic stem cells. PLoS Biol. 2004, 2:E75.
13. Everds N.E. Hematology of the laboratory mouse. The Mouse in Biomedical Research 2006, vol. 3:133-170. Elsevier, Amsterdam. 2nd ed.
14. Sidorov I., Kimura M., Yashin A., Aviv A. Leukocyte telomere dynamics and human hematopoietic stem cell kinetics during somatic growth. Exp. Hematol. 2009, 37:514-524.
15. Bowie M.B., Kent D.G., Dykstra B., McKnight K.D., McCaffrey L., Hoodless P.A., Eaves C.J. Identification of a new intrinsically timed developmental checkpoint that reprograms key hematopoietic stem cell properties. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:5878-5882.
16. Paashuis-Lew Y.R.M., Heddle J.A. Spontaneous mutation during fetal development and post-natal growth. Mutagenesis 1998, 13:613-617.
17. ® mice from fetus to old age: tissue-specific time courses of mutation frequency but similar mutation types. Environ. Mol. Mutagen. 2004, 43:110-120.
18. Lawrence Y.R., Blumenthal D.T., Matceyevsky D., Kanner A.A., Bokstein F., Corn B.W. Delayed initiation of radiotherapy for glioblastoma: how important is it to push to the front (or the back) of the line?. J. Neurooncol. 2011, 105:1-7.
19. Whyatt R.M., Jedrychowski W., Hemminki K., Santella R.M., Tsai W.Y., Yang K. Biomarkers of polycyclic aromatic hydrocarbon-DNA damage and cigarette smoke exposures in paired maternal and newborn blood samples as a measure of differential susceptibility. Cancer Epidemiol. Biomarker Prev. 2001, 10:581-588.
20. Perera F.P., Tang D., Tu Y.H., Cruz L.A., Borjas M., Bernert T., Whyatt R.M. Biomarkers in maternal and newborn blood indicate heightened fetal susceptibility to procarcinogenic DNA damage. Environ. Health Perspect. 2004, 112:1133.
21. Vesselinovitch S.C., Kyriazis A.P., Mihailovich N., Rao K.V. Conditions modifying development of tumors in mice at various sites by benzo(a)pyrene. Cancer Res. 1975, 35:2948-2953.
22. Soyka L.F. Hepatic drug metabolizing enzyme activity and tumorigenesis in mice following perinatal exposure to benzo(a)pyrene. Pediatr. Pharmacol. 1980, 1:85-96.
23. Walker V.E., Jones I.M., Crippen T.L., Meng Q., Walker D.M., Bauer M.J., Reilly A.A., Tates A.D., Nakamura J., Upton P.B., Skopek T.R. Relationships between exposure, cell loss and proliferation, and manifestation of Hprt mutant T cells following treatment of preweanling, weanling, and adult male mice with N-ethyl-N-nitrosourea. Mutat. Res. 1999, 431:371-388.
24. Sussman H.E., Bauer M.J., Shi X., Judice S.A., Albertini R.J., Walker V.E. Transplacental mutagenicity of N-ethyl-N-nitrosourea at the Hprt locus in T-lymphocytes of exposed B6C3F1 mice. Environ. Mol. Mutagen. 2001, 38:30-37.
25. Slikker W., Mei N., Chen T. N-ethyl-N-nitrosourea (ENU) increased brain mutations in prenatal and neonatal mice but not in the adults. Toxicol. Sci. 2004, 81:112-120.
26. Mei N., Heflich R.H., Moore M.M., Chen T. Age-dependent sensitivity of BigBlue transgenic mice to the mutagenicity of N-ethyl-N-nitrosourea (ENU) in liver. Mutat. Res. 2005, 572:14-26.
27. Chen T., Mittelstaedt R.A., Beland F.A., Heflich R.H., Moore M.M., Parsons B.L. 4-Aminobiphenyl induces liver DNA adducts in both neonatal and adult mice but induces liver mutations only in neonatal mice. Int. J. Cancer 2005, 117:182-187.
28. Likhachev A.J., Alekandrov V.A., Anisimov V.N., Bespalov V.G., Korsakov M.V., Ovsyannikov A.I., Popovich I.G., Napalkov N.P., Tomatis L. Persistence of methylated purines in the DNA of various rat fetal and maternal tissues and carcinogenesis in the offspring following a single transplacental dose of N-methyl-N-nitrosourea. Int. J. Cancer 1983, 31:779-784.
29. Coccia P., Salmona M., Diomede L., Citti L., Mariani L., Romano M. Liver DNA alkylation after a single carcinogenic dose of dimethylnitrosamine to newborn and adult CFW Swiss mice. Chem. Biol. Interact. 1988, 68:259-271.
30. 6-methylguanine-DNA methyltransferase and uracil-DNA glycosylase activity in some tissues. Carcinogenesis 1983, 4:1559-1564.
31. Zhu J., Wang H., Yang S., Guo L., Li Z., Wang W., Bi Y. Comparison of toxicity of benzene metabolite hydroquinone in hematopoietic stem cells derived from murine embryonic yolk sac and adult bone marrow. PLoS One 2013, 8:e71153.
32. Mohrin M., Bourke E., Alexander D., Warr M.R., Barry-Holson K., Le Beau M.M., Passegué E. Hematopoietic stem cell quiescence promotes error-prone DNA repair and mutagenesis. Cell Stem Cell 2010, 7:174-185.
33. Liang L., Deng L., Mendonca M.S., Chen Y., Zheng B., Stambrook P.J., Shao C., Tischfield J.A. X-rays induce distinct patterns of somatic mutation in fetal versus adult hematopoietic cells. DNA Repair 2007, 6:1380-1385.
34. Hayashi M., Tice R.R., MacGregor J.T., Anderson D., Blakey D.H., Kirsh-Volders M., Vannier B. In vivo rodent erythrocyte micronucleus assay. Mutat. Res. 1994, 312:293-304.
35. OECD Guideline for the testing of chemicals: mammalian erythrocyte micronucleus test. Guideline 474 1997, OECD, Paris, pp. 1-21.
36. Udroiu I. Feasibility of conducting the micronucleus test in circulating erythrocytes from different mammalian species: an anatomical perspective. Environ. Mol. Mutagen. 2006, 47:643-646.
37. Cihák R., Vontorková M. Cytogenetic effects of quinoxaline-1,4-dioxide-type growth-promoting agents. III. Transplacental micronucleus test in mice. Mutat. Res. 1985, 144:81-84.
38. Cihák R., Vontorková M. Benzidine and 3,3'-dichlorobenzidine (DCB) induce micronuclei in the bone marrow and the fetal liver of mice after gavage. Mutagenesis 1987, 2:267-269.
39. Xing S.G., Shi X., Wu Z.L., Chen J.K., Wallace W., Whong W.Z., Ong T. Transplacental genotoxicity of triethylenemelamine, benzene, and vinblastine in mice. Teratog. Carcinog. Mutagen. 1992, 12:223-230.
40. Ning H., Kado N.Y., Kuzmicky P.A., Hsieh D.P. Benzene-induced micronuclei formation in mouse fetal liver blood, peripheral blood, and maternal bone marrow cells. Environ. Mol. Mutagen. 1991, 18:1-5.
41. De Flora S., Iltcheva M., Balansky R.M. Oral chromium(VI) does not affect the frequency of micronuclei in hematopoietic cells of adult mice and of transplacentally exposed fetuses. Mutat. Res. 2006, 610:38-47.
42. Balansky R.M., Blagoeva P.M. Tobacco smoke-induced clastogenicity in mouse fetuses and in newborn mice. Mutat. Res. 1989, 223:1-6.
43. Fucic A., Stojković R., Miškov S., Zeljezic D., Markovic D., Gjergja R., Demarin V. Transplacental genotoxicity of antiepileptic drugs: animal model and pilot study on mother/newborn cohort. Reprod. Toxicol. 2010, 30:613-618.
44. Heuser V.D., de Andrade V.M., Peres A., de Macedo Braga L.M.G., Chies J.A.B. Influence of age and sex on the spontaneous DNA damage detected by micronucleus test and comet assay in mice peripheral blood cells. Cell Biol. Int. 2008, 32:1223-1229.
45. Zúñiga-González G.M., Batista-González C.M., Gómez-Meda B.C., Ramos-Ibarra M.L., Zamora-Perez A.L., Muñoz-Magallanes T., Ramos-Valdés C., Gallegos-Arreola M.P. Micronuclei in diabetes: folate supplementation diminishes micronuclei in diabetic patients but not in an animal model. Mutat. Res. 2007, 634:126-134.
46. Boike G.M., Deppe G., Young J.D., Gove N.L., Bottoms S.F., Malone J.M., Malviya V.K., Sokol R.J. Chemotherapy in a pregnant rat model. 1. Mitomycin-C: pregnancy-specific kinetics and placental transfer. Gynecol. Oncol. 1989, 34:187-190.
47. Van Calsteren K., Verbesselt R., Van Bree R., Heyns L., de Bruijn E., de Hoon J., Amant F. Substantial variation in transplacental transfer of chemotherapeutic agents in a mouse model. Reprod. Sci. 2011, 18:57-63.
48. Vikram A., Tripathi D.N., Ramarao P., Jena G.B. Evaluation of streptozotocin genotoxicity in rats from different ages using the micronucleus assay. Regul. Toxicol. Pharmacol. 2007, 49:238-244.
49. Islas-González K., González-Horta C., Sánchez-Ramírez B., Reyes-Aragón E., Levario-Carrillo M. In vitro assessment of the genotoxicity of ethyl paraoxon in newborns and adults. Hum. Exp. Toxicol. 2005, 24:319-324.
50. Floyd D.N., Cassoni A.M. Intrinsic radiosensitivity of adult and cord blood lymphocytes as determined by the micronucleus assay. Eur. J. Cancer 1994, 30A:615-620.
51. Bakhmutsky M.V., Joiner M.C., Jones T.B., Tucker J.D. Differences in cytogenetic sensitivity to ionizing radiation in newborns and adults. Radiat. Res. 2014, 181:605-616.
52. Uma Devi P. Radiosensitivity of the developing haemopoietic system in mammals and its adult consequences: animal studies. Br. J. Radiol. 2003, 76:366-372.
53. King M.T., Wild D. Transplacental mutagenesis: The micronucleus test on fetal mouse blood. Hum. Genet. 1979, 51:183-194.
54. Udroiu I., Cristaldi M., Ieradi L.A., Bedini A., Giuliani L., Tanzarella C. Clastogenicity and aneuploidy in newborn and adult mice exposed to 50 Hz magnetic fields. Int. J. Radiat. Biol. 2006, 82:561-567.
55. Erickson R.P. Somatic gene mutation and human disease other than cancer: an update. Mutat. Res. 2010, 705(October (2)):96-106. 10.1016/j.mrrev.2010.04.002.
56. Frank S.A. Somatic evolutionary genomics: mutations during development cause highly variable genetic mosaicism with risk of cancer and neurodegeneration. Proc. Natl. Acad. Sci. U. S. A. 2010, 107(Suppl. 1):1725-1730. January 26.
57. Kleinerman R.A. Cancer risks following diagnostic and therapeutic radiation exposure in children. Pediatr. Radiol. 2006, 36:121-125.
58. Hattis D., Goble R., Russ A., Chu M., Ericson J. Age-related differences in susceptibility to carcinogenesis: a quantitative analysis of empirical animal bioassay data. Environ. Health Perspect. 2004, 112:1152-1158.
59. Greaves M. In utero origins of childhood leukaemia. Early Hum. Dev. 2005, 81:123-129.
60. Harper B.L., Ramanujam V.M., Legator M.S. Micronucleus formation by benzene, cyclophosphamide, benzo(a)pyrene, and benzidine in male, female, pregnant female, and fetal mice. Teratog. Carcinog. Mutagen. 1989, 9:239-252.
61. Müller L. Micronucleus induction in mouse and rat fetuses treated transplacentally during histogenesis with mitomycin C and 7,12-dimethylbenz(a) anthracene. Teratog. Carcinog. Mutagen. 1988, 8:303-313.
62. Stoyel C.J., Clark A.M. The transplacental micronucleus test. Mutat. Res. 1980, 74:393-398.
63. Alaoui-Jamali M.A., Rossignol G., Schuller H.M., Castonguay A. Transplacental genotoxicity of a tobacco-specific N-nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, in Syrian golden hamster. Mutat. Res. 1989, 223:65-72.
64. Udroiu I., Antoccia A., Tanzarella C., Giuliani L., Sgura A. Genotoxic Effects on Mice Irradiated with Elf Magnetic Fields and X-rays During the Fetal and Neonatal Stages 2014, XVI Congress of the Italian Society for Radiation Research, Pavia.
65. Grüneberg H. The growth of the blood of the sucking mouse. J. Path. Bact. 1941, 52:323-329.
66. Baas J.R.B. Erythropoiesis in the Neonatal Mouse 1970, California State University, Northridge, pp. 11-18.